Dr. Imran Ahmad

Associate Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Imran Ahmad. Improve your application with a focused, well-structured draft.

Biography

Imran Ahmad is a hematologist and an Associate Professor at the Université de Montréal, where he serves as the Director of the Cellular Transplantation & Therapy Program within the Clinical Research Unit at Hôpital Maisonneuve-Rosemont. His expertise lies in hematopoietic stem cell transplantation, focusing on conditioning regimens, graft-versus-host disease, and leukemia relapse prevention. He has a solid foundation in clinical research methodology and plays a vital role in several professional organizations, including the American Society of Hematology and the Canadian Donation & Transplantation Research Program. His commitment to research is highlighted by his active involvement in various studies aimed at improving patient care in hematology and oncology. Through his leadership, he coordinates initiatives to enhance clinical practices and research outcomes in the field. Ahmad's work has garnered recognition and he is involved in multiple research affiliations, showcasing his dedication to advancing the field of hematology and cellular therapy.

Research Interests

Experience

Associate Professor

2017-01-01 — Present

Université de Montréal • Montréal, QC, Canada

Serves as the Director of the Cellular Transplantation & Therapy Program within the Clinical Research Unit at Hôpital Maisonneuve-Rosemont.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.